Cancer-associated fibroblasts stimulate an EMT-driven gain of cancer stemness through a paracrine interplay between CAFs and prostate cancer cells (Giannoni et al., 2010), and also constitute a supporting niche for cancer stemness in lung cancer through a paracrine IGF-II/IGF1R signaling (Chen et al., 2014). The gene discussed is IGF2; the disease is cancer.